Happy Thanksgiving

Per Primal tradition, the bees and I are off for the day.

I’ve said before that I consider Thanksgiving to be the most Primal of holidays. The elevated act of preparing and sharing a traditional meal is about as basic—and sacred—as human ceremony gets. It’s like gathering around a fire together. We bask in the comfort of ritual and cycle this time of year. We offer thanks for the year’s blessings.

Each year I say it, and each year I’m filled with the truth of it: I look to this community with heartfelt gratitude. Thank you for reading, for sharing, for contributing. Thank you for carrying the message of health and for supporting each other here.

Today I wish each of you the very best—of health and happiness. However you’re celebrating today, enjoy your holiday, everyone.

The post Happy Thanksgiving appeared first on Mark's Daily Apple.

Four killed in attacks against Ebola response centers in Congo

Four killed in attacks against Ebola response centers in Congo
Reuters: Health
Militia fighters in eastern Congo killed four people and injured several others in attacks on two Ebola response centers on Thursday, in what the United Nations described as a setback to efforts to contain the disease.


There's a new question anti-hunger advocates want doctors & nurses to ask patients: Do you have enough food? - Public health officials say the answer often is "not really." So clinics & hospitals have begun stocking their own food pantries in recent yrs.

There's a new question anti-hunger advocates want doctors & nurses to ask patients: Do you have enough food? - Public health officials say the answer often is "not really." So clinics & hospitals have begun stocking their own food pantries in recent yrs. submitted by /u/anutensil
[link] [comments]


source https://www.reddit.com/r/Health/comments/e2wrom/theres_a_new_question_antihunger_advocates_want/

Profits drive the rising prices of MS drugs in the US, finds a new study based on interviews with four pharmaceutical executives published in Neurology. In Europe, the price of a drug is typically highest when it launches and declines over time. The opposite appears to be the case in the US.

Profits drive the rising prices of MS drugs in the US, finds a new study based on interviews with four pharmaceutical executives published in Neurology. In Europe, the price of a drug is typically highest when it launches and declines over time. The opposite appears to be the case in the US. submitted by /u/mvea
[link] [comments]


source https://www.reddit.com/r/Health/comments/e2x021/profits_drive_the_rising_prices_of_ms_drugs_in/

Hospital visits go up after days with higher levels of air pollution, finds study of over 95 million US hospital records over 13 years. There were 2050 extra hospital admissions and 12,216 extra days in hospital associated with each increase in fine particulate matter by 1 microgram per cubic metre.

Hospital visits go up after days with higher levels of air pollution, finds study of over 95 million US hospital records over 13 years. There were 2050 extra hospital admissions and 12,216 extra days in hospital associated with each increase in fine particulate matter by 1 microgram per cubic metre. submitted by /u/mvea
[link] [comments]


source https://www.reddit.com/r/Health/comments/e2wamt/hospital_visits_go_up_after_days_with_higher/

Profits drive the rising prices of MS drugs in the US, finds a new study based on interviews with four pharmaceutical executives published in Neurology. In Europe, the price of a drug is typically highest when it launches and declines over time. The opposite appears to be the case in the US.

Profits drive the rising prices of MS drugs in the US, finds a new study based on interviews with four pharmaceutical executives published in Neurology. In Europe, the price of a drug is typically highest when it launches and declines over time. The opposite appears to be the case in the US.
Profits drive the rising prices of MS drugs in the US, finds a new study based on interviews with four pharmaceutical executives published in Neurology. In Europe, the price of a drug is typically highest when it launches and declines over time. The opposite appears to be the case in the US. submitted by /u/mvea
[link] [comments]
https://ift.tt/2KWOnZ5 November 28, 2019 at 05:19PM https://ift.tt/1R552o9

Profits drive the rising prices of MS drugs in the US, finds a new study based on interviews with four pharmaceutical executives published in Neurology. In Europe, the price of a drug is typically highest when it launches and declines over time. The opposite appears to be the case in the US.

Profits drive the rising prices of MS drugs in the US, finds a new study based on interviews with four pharmaceutical executives published in Neurology. In Europe, the price of a drug is typically highest when it launches and declines over time. The opposite appears to be the case in the US. submitted by /u/mvea
[link] [comments]